# Nitroglycerin

## Millisrol inj 5mg/10mL

| TAH Drug Code      | [IMIL](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IMIL)                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Control of peri-op hypertension; CHF associated with acute MI. Treatment of angina pectoris unresponsive to recommended doses of organic nitrates &/or a Î²- blocker. Production of controlled hypotension during neurosurgical & orthopedic surgical procedures.                                                                                                                                                                                                                                           |
| Dosing             | Diluted to 0.005-0.05% (50-500 mcg/mL), IV infusion rate: 0.05-5 mcg/kg/minute according to indications and responses. Maintenance of reduced blood pressure during surgery: 1-5 mcg/kg/minute. Emergent treatment for hypertension during surgery: 0.5-5 mcg/kg/minute. Acute heart failure (including the acute exacerbation period of chronic heart failure): Initially 0.05-0.1 mcg/kg/minute, then increase drip rate to 0.1-0.2 mcg/kg/minute every 5-15 minutes until desired response is obtained. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Contraindications  | Glaucoma, severe anemia.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Adverse Effects    | Tachycardia, arrhythmia, sudden drop of BP, deterioration of cardiac output, methemoglobinemia, headache, nausea, vomiting. Cardiovascular: Hypotension Dermatologic: Erythroderma, Flushing, Rash Neurologic: Headache (63% ), Lightheadedness (6% )                                                                                                                                                                                                                                                      |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| More Info          | [UpToDate](https://www.uptodate.com/contents/nitroglycerin-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                               |

## Nitrostat (NTG) 0.6mg

| TAH Drug Code      | [ONTG6](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ONTG6)                                                                                                                                                                                                                                                                                                         |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment & prophylaxis of angina pectoris.                                                                                                                                                                                                                                                                                                                                    |
| Dosing             | Angina pectoris, acute: 0.6 mg sublingually or buccally at 1st sign of acute attack, may be repeated every 5 minutes for 3 doses. If no relief after taking 3 doses within 15 minutes, seek medical attention promptly. Angina pectoris, prophylaxis: 0.6 mg sublingually or buccally 5-10 minutes prior to the activity which may precipitate an attack.                      |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                  |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                  |
| Contraindications  | Severe anemia; raised intracranial pressure, early MI, patients taking sildenafil.                                                                                                                                                                                                                                                                                             |
| Adverse Effects    | Headache, vertigo, weakness, palpitation & postural hypotension. Marked sensitivity to the hypotensive effects of nitrates (manifested by nausea, vomiting, weakness, diaphoresis, pallor & collapse). Flushing, drug rash & exfoliative dermatitis. Cardiovascular: Hypotension Dermatologic: Erythroderma, Flushing, Rash Neurologic: Headache (63% ), Lightheadedness (6% ) |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                    |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                  |
| More Info          | [UpToDate](https://www.uptodate.com/contents/nitroglycerin-drug-information)                                                                                                                                                                                                                                                                                                   |

